Activation of Mitogen-activated Protein (MAP) Kinase Pathway by Pervanadate, a Potent Inhibitor of Tyrosine Phosphatases
Open Access
- 1 September 1996
- journal article
- Published by Elsevier BV
- Vol. 271 (36), 22251-22255
- https://doi.org/10.1074/jbc.271.36.22251
Abstract
No abstract availableThis publication has 23 references indexed in Scilit:
- Roles of Protein-tyrosine Phosphatases in Stat1α-mediated Cell SignalingPublished by Elsevier BV ,1995
- Inactivation of p42 MAP kinase by protein phosphatase 2A and a protein tyrosine phosphatase, but not CL100, in various cell linesCurrent Biology, 1995
- Protein kinases and phosphatases: The Yin and Yang of protein phosphorylation and signalingCell, 1995
- Specificity of receptor tyrosine kinase signaling: Transient versus sustained extracellular signal-regulated kinase activationCell, 1995
- The ins and outs of Raf kinasesTrends in Biochemical Sciences, 1994
- Raf meets Ras: completing the framework of a signal transduction pathwayTrends in Biochemical Sciences, 1994
- Diversity in function and regulation of MAP kinase pathwaysTrends in Biochemical Sciences, 1994
- The MAP kinase cascade is essential for diverse signal transduction pathwaysTrends in Biochemical Sciences, 1993
- Orthovanadate both mimics and antagonizes the transforming growth factor β action on normal rat kidney cellsJournal of Cellular Physiology, 1993
- Transformation of cells by an inhibitor of phosphatases acting on phosphotyrosine in proteinsCell, 1985